CVS Health Corp
SWB:CVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
CVS Health Corp (CVS) under the Base Case is 90.98 EUR per share.
Compared with the current market price of 79.24 EUR, the stock appears
Undervalued by 13% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What CVS Health Does
CVS Health is a U.S. health care company built around pharmacies, pharmacy benefits, and insurance. It runs retail drugstores and fills prescriptions for walk-in customers, but a big part of its business comes from helping employers, insurers, and government plans manage prescription drug costs through its pharmacy benefit manager, CVS Caremark. It also owns Aetna, which sells health insurance plans to individuals, employers, and Medicare members.
- Headquarters
- United States of America US
- Employees
- 300 000
- IPO date
- Oct 1, 1952
CVS Health has no economic moat
Customers and health plans can choose other pharmacies, insurers and pharmacy-benefit providers, so CVS has no lasting barrier that prevents rivals from winning their business. Familiarity with CVS alone does not make customers stay when other providers offer alternatives.
Read the full moat analysis
Revenue & Expenses Breakdown
CVS Health Corp
Earnings Waterfall
CVS Health Corp
What is the Intrinsic Value of one CVS stock?
The intrinsic value for CVS Health Corp (CVS) under the Base Case is 90.98 EUR.
Is CVS stock undervalued or overvalued?
Compared with the current market price of 79.24 EUR, the stock appears Undervalued by 13% .
